Funder
Japan Society for the Promotion of Science
Reference58 articles.
1. Cognitive functioning and positive and negative symptoms in schizophrenia;Addington;Schizophr. Res.,1991
2. Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders;Anderson;Psychiatr. Res.,2015
3. The impact of aging, psychotic symptoms, medication, and brain-derived neurotrophic factor on cognitive impairment in Japanese chronic schizophrenia patients;Atake;Front. Psychiatr.,2018
4. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness;Barnes;Health Technol. Assess.,2017
5. Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine;Bender;Int. J. Neuropsychopharmacol.,2006